Affectis Pharmaceuticals' Series C Round

Affectis Pharmaceuticals raised a round of funding on October 24, 2006.

Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.…

Articles about Affectis Pharmaceuticals' Series C Round: